Blueshift Ideas Says Thoratec Corporation Will Dominate
The company's competitor, HeartWare International Inc (NASDAQ: HTWR), has a device that is expected to compete with Thoratec for the next generation device.
Blueshift says that Thoratec's first to market position and reputation in the medical community will help it in the coming months.
According to Blueshift, "Sources universally expect use of LVAD's to grow, with four expecting the market to double to triple worldwide during the next five years."
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.